Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The differential diagnosis of IgG4-related disease based on machine learning.
Yamamoto M, Nojima M, Kamekura R, Kuribara-Souta A, Uehara M, Yamazaki H, Yoshikawa N, Aochi S, Mizushima I, Watanabe T, Nishiwaki A, Komai T, Shoda H, Kitagori K, Yoshifuji H, Hamano H, Kawano M, Takano KI, Fujio K, Tanaka H. Yamamoto M, et al. Among authors: nojima m. Arthritis Res Ther. 2022 Mar 19;24(1):71. doi: 10.1186/s13075-022-02752-7. Arthritis Res Ther. 2022. PMID: 35305690 Free PMC article.
Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment.
Yamamoto M, Nojima M, Takahashi H, Yokoyama Y, Ishigami K, Yajima H, Shimizu Y, Tabeya T, Matsui M, Suzuki C, Naishiro Y, Takano K, Himi T, Imai K, Shinomura Y. Yamamoto M, et al. Among authors: nojima m. Rheumatology (Oxford). 2015 Jan;54(1):45-9. doi: 10.1093/rheumatology/keu228. Epub 2014 Jun 6. Rheumatology (Oxford). 2015. PMID: 24907151
Predicting therapeutic response in IgG4-related disease based on cluster analysis.
Yamamoto M, Takano KI, Kamekura R, Suzuki C, Tabeya T, Murakami R, Honda S, Mukai M, Nojima M, Ichimiya S, Himi T, Nakase H, Takahashi H. Yamamoto M, et al. Among authors: nojima m. Immunol Med. 2018 Mar;41(1):30-33. doi: 10.1080/09114300.2018.1451613. Epub 2018 Apr 3. Immunol Med. 2018. PMID: 30938256
Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial.
Yuki Y, Nojima M, Hosono O, Tanaka H, Kimura Y, Satoh T, Imoto S, Uematsu S, Kurokawa S, Kashima K, Mejima M, Nakahashi-Ouchida R, Uchida Y, Marui T, Yoshikawa N, Nagamura F, Fujihashi K, Kiyono H. Yuki Y, et al. Among authors: nojima m. Lancet Microbe. 2021 Sep;2(9):e429-e440. doi: 10.1016/S2666-5247(20)30196-8. Epub 2021 Jun 25. Lancet Microbe. 2021. PMID: 35544149 Free article. Clinical Trial.
Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors.
Kamimae S, Yamamoto E, Yamano HO, Nojima M, Suzuki H, Ashida M, Hatahira T, Sato A, Kimura T, Yoshikawa K, Harada T, Hayashi S, Takamaru H, Maruyama R, Kai M, Nishiwaki M, Sugai T, Sasaki Y, Tokino T, Shinomura Y, Imai K, Toyota M. Kamimae S, et al. Among authors: nojima m. Cancer Prev Res (Phila). 2011 May;4(5):674-83. doi: 10.1158/1940-6207.CAPR-10-0214. Cancer Prev Res (Phila). 2011. PMID: 21543345
467 results